Research shows that nearly 6 out of 10 kidney dialysis patients (59%) have malnutrition, with 83% experiencing reduced muscle mass, according to a 2026 cross-sectional study of 128 dialysis patients in the Netherlands. Gram Research analysis found that 23% have severe muscle loss (sarcopenia) and 5% have both muscle loss and excess body fat simultaneously. These nutrition problems frequently occur together, suggesting doctors need better screening tools to identify and treat muscle loss early in dialysis patients.
A new study of 128 kidney dialysis patients in the Netherlands found that muscle loss and malnutrition are extremely common problems affecting their health and quality of life. Researchers discovered that nearly 6 out of 10 dialysis patients show signs of malnutrition, with 83% experiencing reduced muscle mass. The study also found that these nutrition problems often happen together, making it harder to treat them. According to Gram Research analysis, these findings suggest doctors need better screening tools to catch and treat muscle loss early in dialysis patients, which could help them live longer and feel better.
Key Statistics
A 2026 cross-sectional study of 128 kidney dialysis patients in the Netherlands found that 59% met criteria for malnutrition, with reduced muscle mass being the most prevalent sign at 83% of patients.
According to research reviewed by Gram, 23% of dialysis patients had sarcopenia (severe muscle loss) and 38% had protein-energy wasting, with significant overlap between these conditions in the same individuals.
A 2026 study of 128 dialysis patients found that the PG-SGA assessment tool identified malnutrition in 98% of 39 patients tested, compared to 47% using the SGA tool on 89 patients, showing how diagnostic method choice dramatically affects detection rates.
Research from 2026 showed that sarcopenic obesity (simultaneous muscle loss and excess body fat) affected 5% of 128 dialysis patients, representing an emerging nutrition problem in this population.
The Quick Take
- What they studied: How common are muscle loss, malnutrition, and related nutrition problems in people receiving kidney dialysis treatment?
- Who participated: 128 adult patients receiving regular kidney dialysis treatment at multiple hospitals in the Netherlands. Researchers measured their muscle mass, muscle strength, and nutrition status using several different methods.
- Key finding: Nearly 6 out of 10 dialysis patients (59%) showed signs of malnutrition, and 83% had reduced muscle mass. About 1 in 4 patients (23%) had sarcopenia (severe muscle loss), and 5% had both muscle loss and excess body fat at the same time.
- What it means for you: If you or a loved one receives kidney dialysis, ask your doctor about screening for muscle loss and malnutrition. Early detection and treatment with proper nutrition and exercise may help prevent serious complications and improve quality of life. However, this study shows what exists, not whether treatment works, so talk to your healthcare team about personalized options.
The Research Details
This was a cross-sectional study, which means researchers looked at a group of people at one point in time rather than following them over months or years. They studied 128 kidney dialysis patients from multiple hospitals in the Netherlands and measured their body composition (muscle and fat) using three different types of bioimpedance analysis, basically machines that send small electrical signals through the body to estimate muscle and fat amounts. They also tested hand grip strength to measure muscle function and used several established assessment tools (GLIM, PEW, SGA, PG-SGA, EWGSOP2, and SOGLI) to diagnose malnutrition and muscle loss. Each tool uses different criteria, so researchers could compare which methods caught the most cases.
The researchers used Venn diagrams to show how these nutrition problems overlapped, meaning they identified patients who had multiple conditions at the same time. This approach helped them understand whether these are separate problems or different ways of describing the same underlying issue. The study was conducted in 2026 and included only adult patients receiving regular hemodialysis treatment.
This research approach matters because kidney dialysis patients are at very high risk for nutrition problems, but doctors don’t always agree on the best way to diagnose them. By testing multiple diagnostic tools on the same patients, this study shows which methods work best and how often these problems actually occur together. Understanding the overlap helps doctors avoid missing cases and prevents unnecessary duplicate testing. The cross-sectional design gives a clear snapshot of the problem’s size, which is the first step toward developing better screening and treatment programs.
Strengths: The study included 128 patients from multiple hospitals, making results more representative. Researchers used multiple established diagnostic tools, allowing comparison of different approaches. They measured body composition objectively using machines rather than relying only on patient reports. Limitations: The study only looked at one moment in time, so it can’t prove that malnutrition causes poor health outcomes. All patients were from the Netherlands, so results may not apply to other countries with different dialysis practices. The study didn’t follow patients to see if treatment improved their outcomes. Some assessment tools were only used on subsets of patients (89 for SGA, 39 for PG-SGA), which limits comparison.
What the Results Show
The study found that malnutrition and muscle loss are extremely common in kidney dialysis patients. Using the GLIM criteria (a standard malnutrition assessment), 59% of patients were classified as malnourished, meaning nearly 6 out of 10 dialysis patients have this problem. The most common sign was reduced muscle mass, found in 83% of patients. Protein-energy wasting (a specific type of malnutrition common in kidney disease) was present in 38% of patients. Sarcopenia (severe muscle loss affecting strength and function) was diagnosed in 23% of patients using the EWGSOP2 criteria. Sarcopenic obesity (having both muscle loss and excess body fat) was found in 5% of patients.
When researchers used different diagnostic tools, they found different rates of malnutrition. The SGA tool identified moderate-to-severe malnutrition in 47% of 89 patients tested. The PG-SGA tool, which includes patient input, found malnutrition in 98% of 39 patients tested, an extremely high rate. This big difference shows that how doctors diagnose malnutrition matters a lot. The GLIM criteria showed the most overlap with other diagnostic frameworks, meaning it caught cases that other tools also identified, suggesting it may be the most reliable single screening method.
The study revealed that these nutrition problems frequently occur together in the same patient. Many dialysis patients had multiple conditions simultaneously, for example, someone might have both malnutrition and sarcopenia, or sarcopenia and obesity. This overlap is important because it means treating one problem might help with others. The study also showed that reduced muscle mass was by far the most common finding (83% of patients), suggesting that muscle loss is the central problem in dialysis-related malnutrition. Hand grip strength measurements confirmed that muscle loss was real and functional, not just a measurement artifact. The fact that 98% of patients showed malnutrition signs when using the PG-SGA tool (which includes patient-reported symptoms) suggests that patients themselves notice nutrition problems even when doctors might miss them using other methods.
This study confirms what previous research has suggested: malnutrition and muscle loss are major problems in kidney dialysis patients. Earlier studies reported malnutrition rates ranging from 20-50% depending on the diagnostic tool used, and this study’s 59% rate using GLIM falls within that range. The finding that 23% have sarcopenia is consistent with previous research showing that muscle loss affects about 1 in 5 to 1 in 4 dialysis patients. However, this study is novel in directly comparing multiple diagnostic tools on the same patients and showing how much they overlap. Previous research often used only one diagnostic method, so this side-by-side comparison provides new insight. The study also adds to growing evidence that sarcopenic obesity (muscle loss with excess fat) is an emerging problem in dialysis patients, though still relatively uncommon at 5%.
This study has several important limitations. First, it’s a snapshot in time, so it can’t prove that malnutrition causes poor health outcomes or death, only that it exists. Second, the study only included patients from the Netherlands, so results may not apply to dialysis patients in other countries with different treatment approaches or dietary patterns. Third, some diagnostic tools were only used on subsets of patients, making it impossible to compare all tools on all patients. Fourth, the study didn’t include information about patients’ actual dietary intake, so it’s unclear whether malnutrition is due to not eating enough, poor absorption, or other factors. Fifth, the study didn’t measure whether treatment improved outcomes, so we don’t know if identifying these problems leads to better health. Finally, the study used different body composition measurement methods (three types of bioimpedance analysis), which may have introduced slight variations in results.
The Bottom Line
Healthcare providers should screen all kidney dialysis patients for malnutrition and muscle loss using standardized tools like GLIM, which this study suggests is effective and shows good overlap with other methods. Patients with identified malnutrition or muscle loss should receive nutrition counseling and may benefit from protein supplementation, resistance exercise programs, and close monitoring. Patients should report symptoms like weakness, loss of appetite, or difficulty with daily activities to their dialysis team. While this study doesn’t prove that treatment works, early identification allows doctors to intervene before problems become severe. Confidence level: Moderate: this study clearly shows the problem exists, but more research is needed on which treatments work best.
This research is most relevant for people receiving kidney dialysis, their family members, and their healthcare providers. Nephrologists (kidney doctors) and dialysis center staff should use these findings to improve screening practices. Dietitians working with dialysis patients should be aware of how common these problems are. Patients who feel weak, tired, or notice muscle loss should discuss these findings with their dialysis team. This research is less relevant for people with healthy kidneys or those in early stages of kidney disease, though it may motivate them to protect their kidney function.
Malnutrition and muscle loss develop gradually in dialysis patients, often over months to years. Screening should happen regularly, at least every few months, to catch problems early. If treatment is started, improvements in muscle strength might appear within 4-8 weeks with consistent exercise and nutrition support, though rebuilding significant muscle mass typically takes several months. Patients should not expect overnight changes but should see gradual improvement with proper management.
Frequently Asked Questions
What percentage of kidney dialysis patients have malnutrition?
A 2026 study of 128 dialysis patients found that 59% met malnutrition criteria using the GLIM assessment tool, with 83% showing reduced muscle mass. When using the PG-SGA tool, the rate reached 98%, showing that detection depends heavily on which diagnostic method doctors use.
Can kidney dialysis patients develop muscle loss even if they’re overweight?
Yes. The 2026 study found that 5% of dialysis patients had sarcopenic obesity, meaning they had both severe muscle loss and excess body fat simultaneously. This occurs because dialysis affects muscle differently than fat, allowing both problems to exist at once.
How common is sarcopenia in people on kidney dialysis?
According to a 2026 study of 128 dialysis patients, sarcopenia (severe muscle loss affecting strength and function) was diagnosed in 23% of patients using standard criteria. This means roughly 1 in 4 to 1 in 5 dialysis patients experience this serious muscle problem.
What’s the best way to diagnose malnutrition in dialysis patients?
A 2026 study comparing multiple diagnostic tools found that GLIM criteria showed the greatest overlap with other assessment frameworks, suggesting it may be the most reliable single screening method for malnutrition in dialysis patients. However, using patient-reported symptoms (PG-SGA) catches more cases than doctor-only assessments.
Do dialysis patients usually have just one nutrition problem or multiple at once?
The 2026 study found significant overlap, meaning many dialysis patients have multiple nutrition problems simultaneously, for example, both malnutrition and muscle loss, or muscle loss combined with excess body fat. This overlap suggests these conditions are interconnected in dialysis patients.
Want to Apply This Research?
- Track hand grip strength monthly using a home grip strength meter (inexpensive devices available online). Record the measurement in the app with date and time. Compare month-to-month to detect decline early or confirm improvement from treatment. Also track body weight weekly and note any unintended weight loss, which may indicate worsening malnutrition.
- Set daily protein intake goals based on your dialysis team’s recommendations (typically 1.0-1.2 grams per kilogram of body weight). Log protein-containing foods at each meal in the app. Add two 10-minute resistance exercise sessions weekly using light weights or resistance bands, logging completion in the app. These specific, measurable actions directly address the muscle loss problem identified in this research.
- Create a monthly check-in reminder to assess muscle-related symptoms: Do you feel weaker than last month? Can you carry groceries or climb stairs as easily? Log these observations. Share monthly grip strength and weight trends with your dialysis team during regular appointments. If you notice declining strength or unintended weight loss, alert your healthcare provider immediately rather than waiting for the next scheduled visit.
This research describes the prevalence of malnutrition and muscle loss in kidney dialysis patients but does not evaluate specific treatments. If you receive kidney dialysis or have chronic kidney disease, consult your nephrologist or renal dietitian before making changes to your diet, exercise routine, or treatment plan. This article is for educational purposes and should not replace professional medical advice. Nutrition and exercise recommendations must be individualized based on your specific kidney function, dialysis prescription, and overall health status.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
